Ischemic Stroke Mechanisms and Therapeutic Approaches

Ischemic stroke is precipitated by the sudden obstruction of cerebral blood flow, initiating a cascade of events that culminate in neuronal death and lasting neurological deficits. Energy failure within affected tissues disrupts ionic gradients, leading to excessive release of glutamate and resultant excitotoxicity. Intracellular calcium overload triggers mitochondrial dysfunction and the generation of reactive oxygen species, which in turn fuel lipid peroxidation and DNA damage. Concurrently, astrocytes and microglia become activated, orchestrating a neuroinflammatory response that enhances blood–brain barrier permeability through actin-mediated junctional disassembly and allows peripheral immune cell infiltration. Although rapid reperfusion via thrombolytic agents and mechanical thrombectomy remains essential, restoration of blood flow can paradoxically exacerbate injury by promoting oxidative stress and inflammation. Therapeutic strategies are now expanding beyond single-target approaches to embrace combined modalities: small-molecule inhibitors of excitotoxic receptors, antioxidants that scavenge free radicals, anti-inflammatory agents that recalibrate immune responses, and vascular stabilisers that preserve endothelial integrity. Innovative techniques, such as photobiomodulation to accelerate clearance of toxic metabolites, and interventions designed to modulate cytoskeletal dynamics, are under investigation. The integration of these diverse tactics into synergistic treatment regimens holds promise for reducing infarct size, preventing reperfusion injury and enhancing functional recovery.

Research from Nature Portfolio

Contemporary studies have elucidated the pivotal role of early blood–brain barrier disruption in stroke pathogenesis, driven by rapid endothelial cytoskeletal reorganisation. Activation of Rho-associated kinase induces persistent actin polymerisation, leading to junctional protein disassembly independent of classical matrix metalloproteinase activity. This early opening of the barrier permits entry of peripheral leukocytes, amplifying secondary injury. Experimental modulation of actin-binding proteins has been shown to attenuate both acute and delayed barrier impairment, resulting in preserved tissue structure and improved neurological outcomes in animal models.

Ischemic Stroke Mechanisms and Therapeutic Approaches publication trend

The graph below shows the total number of articles in ischemic stroke mechanisms and therapeutic approaches across all publications each year (not limited to Nature Index journals).

Technical terms

Excitotoxicity: Neuronal injury caused by excessive stimulation of glutamate receptors leading to calcium overload and cell death.

Blood–brain barrier (BBB): A specialised endothelial interface that regulates molecular and cellular traffic between the bloodstream and brain tissue.

Reperfusion injury: Tissue damage that occurs when blood supply returns to the brain after a period of ischaemia, often driven by oxidative stress and inflammation.

Neuroinflammation: Activation of glial cells and peripheral immune responses within the central nervous system following injury.

Photobiomodulation: Therapeutic use of light to modulate cellular processes, such as enhancing molecular transport in the brain extracellular space.

References

1. Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets. Signal Transduction and Targeted Therapy (2024).
2. Accelerated Molecular Transportation in the Brain Extracellular Space with 755-nm Light Attenuates Post-Stroke Cognitive Impairment in Rats. Cyborg and Bionic Systems (2025).
3. Free Radical Damage in Ischemia‐Reperfusion Injury: An Obstacle in Acute Ischemic Stroke after Revascularization Therapy. Oxidative Medicine and Cellular Longevity (2018).
4. Rapid endothelial cytoskeletal reorganization enables early blood–brain barrier disruption and long-term ischaemic reperfusion brain injury. Nature Communications (2016).
5. Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions. Signal Transduction and Targeted Therapy (2022).
6. Targeting Oxidative Stress and Inflammation to Prevent Ischemia-Reperfusion Injury. Frontiers in Molecular Neuroscience (2020).
7. Anti-Inflammatory Targets for the Treatment of Reperfusion Injury in Stroke. Frontiers in Neurology (2017).